Register for our free email digests:
Latest From Evelo Biosciences Inc.
Flagship Pioneering founder and CEO Noubar Afeyan says "watch this space" for another new start-up financing after Evelo Biosciences' successful $50m raising.
Two of the VC's biotechs merged to create an immuno-microbiome company, while Seres is working with Emulate on better tech for microbiome research. UK specialty pharma Martindale acquired small hospital products-focused UK firm Viridian, and Bayer and X-Chem expanded their drug discovery alliance.
Start-ups raised $2.41 billion in Q4 2015. Biopharma companies penned 29 alliances; seven acquisitions were signed in the biopharma and diagnostics industries.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
- Drug Discovery Tools
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Biovista Inc.
- Senior Management
Andreas Persidis, PhD, CEO
Graham Anthony, CFO
- Contact Info
Phone: (434) 971-1141
2421 Ivy Rd.
Charlottesville, VA 22903
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.